Oncologists may
successfully manage their patients with cancer by following
treatment guidelines, but they come up short when it comes to
prescribing simple measures to enhance their patients' health,
according toAnn Partridge, MD, MPH, of Dana-Farber Cancer
Institute, Boston, who spoke on the topic at the recent Best of
ASCO meeting in Miami.
"This is the softer side
of oncology, and we don't pay as much attention to it as we should,
but in our practices these are the things that patients often ask
us about," she said. "Helping patients modify health-related
behaviors should be viewed as an important part of our job."
Psychosocial Problems
Are an Unmet Need
Psychosocial problems and their accompanying
impairments are common among patients and survivors. "Some would
argue that stress is the 6th vital sign," she said. Psychosocial
distress not only takes an emotional toll, but can also reduce
treatment compliance, thus [resulting in poorer outcomes] as well,"
she said.
But clinicians rarely
look for signs of psychosocial distress. At most, 15% or so of
clinicians report using validated scales. "We care about this on
paper, but studies show we are not routinely screening," she said.
"We need to ask the patient, 'How are you doing with this
[distress]?'-the same way we ask about smoking."
Guidelines and
recommendations already exist to help clinicians identify
psychosocial distress. "We just need to generate interest among
providers in adopting them," Dr. Partridge suggested.
Nutrition, Exercise:
What Patients Should Know
Oncologists might have
one-third fewer patients if the public adopted a healthier
lifestyle, according to the American Institute of Cancer Research
and the World Cancer Research Fund. Their analysis has shown that
about one-third of cancers are preventable through lifestyle
modifications of diet, physical activity, body size, and alcohol
intake-not including smoking, injection drug use, and
bacterial/viral infections. The percentage that are preventable
rises to 70% for endometrial cancer, 69% for esophageal cancer, and
almost 50% for stomach and colon cancers.
In terms of nutrition,
the bulk of the evidence pertains to primary cancer prevention,
though data are emerging to show benefits in survivorship and
guidelines are being developed to reflect that. In fact, the health
benefits of good nutrition among cancer patients have gone from
being hypothetical to becoming measurable and established,
according toKimberly Robien, PhD, who discussed the topic at an
ASCO educational session.
For breast cancer, at
least in the Nurses Health Study population, postdiagnosis weight
gain was associated with a 40% to 60% increased risk of recurrence,
breast cancer mortality, and all-cause mortality.1 In
the Women's Intervention Nutrition Study (WINS), an intervention
counteracted this: A low-fat diet significantly reduced not only
weight but recurrence rates, especially in the estrogen-negative
population.2 While a lack of beneficial effect was seen
for a low-fat diet in the Women's Healthy Eating and Living (WHEL)
study, a healthful diet at baseline may have been responsible for
this.3
As for exercise, at least
in colorectal cancer, moderate activity has been associated with a
40% to 50% reduction in recurrence, disease-specific mortality, and
all-cause mortality.4
Altogether, according to
Dr. Partridge, the evidence strongly suggests that a healthy diet
protects against comorbidity and is probably beneficial in
preventing recurrent or progressive disease. There are possible
effects on depression, fatigue, adverse body composition changes,
and functional decline.
The data for the value of
exercise are stronger: Clear effects are seen on adverse changes in
body composition, functional decline, and comorbidity; probable
benefits are observed on recurrence/progression and fatigue; and
possible benefits are seen in depression.
Oncologists can now,
therefore, emphasize to cancer survivors the value of following
dietary and physical activity guidelines, Dr. Partridge said.
"The problem is that
although it's a no-brainer to recommend that people try to eat well
and exercise, it's hard for our patients to do," she acknowledged.
"We need to figure out how to help them."
Alcohol and
Supplements
Reports of a link between
alcohol and breast cancer have raised patients' concerns; drinking
has also been linked to renal and head and neck cancers. The data
are conflicting regarding the effect of alcohol on breast cancer
recurrence: some studies show little to no effect, while others
show a dose-related effect of increasing alcohol intake on
increasing risk of recurrence. To further confuse matters, alcohol
may be cardioprotective.
"We generally recommend
one glass of wine or less per day to our patients," she said. She
does not recommend vitamin supplements, as no reliable body of data
yet show a beneficial effect for their use.
Unfortunately, despite
excellent recommendations, the average patient demonstrates
unhealthy lifestyle practices and behaviors, Dr. Partridge
concluded, citing the following prevalence rates:
- Overweight or obese: 59%-71%
- Diet includes < 5 daily servings of fruits and vegetables:
52%-58%
- Moderate to heavy alcohol intake: 16%
- Sedentary lifestyle: 70%
These figures only
accentuate the mandate for oncologists. "Cancer incites a teachable
moment for lifestyle change," she said. "We can have a positive
impact on health behaviors of survivors and family members." ■
References
1. Kroenke CH, Chen WY,
Rosner B, et al: Weight, weight gain, and survival after breast
cancer diagnosis. J Clin
Oncol 23:1370-1378, 2005.
2. Blackburn GL, Wang
KA: Dietary fat reduction and breast cancer outcome: Results from
the Women's Intervention Nutrition Study (WINS). Am J Clin
Nutr 86:878S-881S, 2007.
3. Pierce JP, Natarajan
L, Caan BJ, et al: Influence of a diet very high in vegetables,
fruit and fiber and low in fact on prognosis following treatment
for breast cancer: The Women's Healthy Eating and Living (WHEL)
randomized trial. JAMA
298:289-298, 2007.
4. Meyerhardt JA, Heseltine D, Niedzwiecki D, et al: Impact of
physical activity on cancer recurrence and survival in patients
with stage III colon cancer: Findings from CALGB 89803. J Clin
Oncol 24:3535-3541, 2006.